Evidence map›Paper›PMID 41361344›Full record

ArticleScientific reports2025

Development of an AI-based magnetic resonance imaging reading support program (AMP) for deep endometriosis diagnosis.

Rie Shiokawa, Junichiro Iwasawa, Yumiko Oishi Tanaka, Yuta Tokuoka, Yohei Sugawara, Yuichiro Hirano, Ryo Takaji, Yayoi Hayakawa, Keita Oda, Yasunori Kudo and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rie ShiokawaChugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception12F), Chuo-ku, Tokyo, 103-8324, Japan. shiokaware@chugai-pharm.co.jp.
Junichiro IwasawaPreferred Networks, Inc., Tokyo, 100-0004, Japan.
Yumiko Oishi TanakaDiagnostic Imaging Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 135-8550, Japan.
Yuta TokuokaPreferred Networks, Inc., Tokyo, 100-0004, Japan.
Yohei SugawaraPreferred Networks, Inc., Tokyo, 100-0004, Japan.
Yuichiro HiranoDepartment of Radiology, IUHW Narita Hospital, Chiba, 286-8520, Japan.
Ryo TakajiDepartment of Radiology, Oita University Faculty of Medicine, Oita, 879- 5593, Japan.
Yayoi HayakawaDepartment of Radiology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.
Keita OdaPreferred Networks, Inc., Tokyo, 100-0004, Japan.
Yasunori KudoPreferred Networks, Inc., Tokyo, 100-0004, Japan.
Miho LiChugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception12F), Chuo-ku, Tokyo, 103-8324, Japan.
Kazue MizunoPreferred Networks, Inc., Tokyo, 100-0004, Japan.
Kazuhisa OzekiChugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception12F), Chuo-ku, Tokyo, 103-8324, Japan.
Ayako Nishimoto-KakiuchiChugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception12F), Chuo-ku, Tokyo, 103-8324, Japan.
Kimio TeraoChugai Pharmaceutical Co., Ltd., 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception12F), Chuo-ku, Tokyo, 103-8324, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosis of endometriosis faces significant challenges including diagnostic delay and reliance on invasive procedures. Deep endometriosis (DE) poses additional difficulties in non-invasive diagnosis due to its subtle and complex imaging features. To address these challenges, we developed an AI-based MRI reading support program (AMP) designed to improve diagnostic accuracy and efficiency, with the primary endpoint of demonstrating its potential to enhance radiologists' reading sensitivity. AMP comprises the following three models: (1) a nnU-Net model for endometriotic nodular lesion (plaque) segmentation, (2) a radiomics-based LightGBM model for adhesion detection, and (3) a nnU-Net model for detection/quantification of ovarian endometriotic cysts (OECs). In cross-validation, AMP achieves mean Dice similarity coefficient of 0.293 for plaque segmentation and 0.580 for OEC segmentation. For adhesion detection, AMP shows high performance for uterine adhesions (F1 scores > 0.6). In a preliminary clinical utility study with three radiologists, AMP improved mean recall for plaque detection from 0.73 to 0.91 demonstrating AMP's ability to support radiologists in identifying subtle DE lesions and adhesions. Our findings show that AMP is a reliable non-invasive clinical diagnosis tool, that has the potential to minimize diagnostic delays and improve patient outcome.

Indexed as

Artificial IntelligenceEndometriosisImage Interpretation, Computer-AssistedMagnetic Resonance ImagingAdultFemaleHumansArtificial intelligenceDeep endometriosisDiagnosisMachine learningMRIRadiologist

Identifiers

PMID41361344
PMCPMC12780234

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.